[go: up one dir, main page]

DE202007016505U1 - Re-Vital Kapseln für Männer - Google Patents

Re-Vital Kapseln für Männer Download PDF

Info

Publication number
DE202007016505U1
DE202007016505U1 DE202007016505U DE202007016505U DE202007016505U1 DE 202007016505 U1 DE202007016505 U1 DE 202007016505U1 DE 202007016505 U DE202007016505 U DE 202007016505U DE 202007016505 U DE202007016505 U DE 202007016505U DE 202007016505 U1 DE202007016505 U1 DE 202007016505U1
Authority
DE
Germany
Prior art keywords
capsules
men
vital
maca
taurine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE202007016505U
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ROEPER SIYKA
Roper Siyka Dr
Original Assignee
ROEPER SIYKA
Roper Siyka Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ROEPER SIYKA, Roper Siyka Dr filed Critical ROEPER SIYKA
Priority to DE202007016505U priority Critical patent/DE202007016505U1/de
Publication of DE202007016505U1 publication Critical patent/DE202007016505U1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/255—Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medical Informatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"Re-Vital Kapseln für Männer" dadurch gekennzeichnet, dass sie sich aus einer Wirkstoffkombination von L-Arginin, Maca, Taurin und Austernextrakt in folgendem Verhältnis zusammensetzen:
400 mg L-Arginin
60 mg Maca
50 mg Taurin
17 mg Austernextrakt

Description

Kapseln zum Einnehmen mit (je Kapsel)
  • 400 mg L-Arginin
  • 60 mg Maca
  • 50 mg Taurin
  • 17 mg Austernextrakt

Claims (1)

  1. "Re-Vital Kapseln für Männer" dadurch gekennzeichnet, dass sie sich aus einer Wirkstoffkombination von L-Arginin, Maca, Taurin und Austernextrakt in folgendem Verhältnis zusammensetzen: 400 mg L-Arginin 60 mg Maca 50 mg Taurin 17 mg Austernextrakt
DE202007016505U 2007-11-26 2007-11-26 Re-Vital Kapseln für Männer Expired - Lifetime DE202007016505U1 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE202007016505U DE202007016505U1 (de) 2007-11-26 2007-11-26 Re-Vital Kapseln für Männer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE202007016505U DE202007016505U1 (de) 2007-11-26 2007-11-26 Re-Vital Kapseln für Männer

Publications (1)

Publication Number Publication Date
DE202007016505U1 true DE202007016505U1 (de) 2008-02-14

Family

ID=39079271

Family Applications (1)

Application Number Title Priority Date Filing Date
DE202007016505U Expired - Lifetime DE202007016505U1 (de) 2007-11-26 2007-11-26 Re-Vital Kapseln für Männer

Country Status (1)

Country Link
DE (1) DE202007016505U1 (de)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102362685A (zh) * 2011-10-24 2012-02-29 浙江省医学科学院 一种玛咖复方饮料及其制备方法
CN103445165A (zh) * 2013-09-04 2013-12-18 百丽晨（上海）生物科技有限公司 一种用于改善亚健康状态的产品及其组合物
CN103734740A (zh) * 2013-12-26 2014-04-23 永安康健药业（武汉）有限公司 具机能调理作用的玛咖复方保健食品及制备方法
CN104905243A (zh) * 2015-01-06 2015-09-16 江苏丰颂生物科技有限公司 一种具有抗疲劳功能的玛咖生蚝组合物及其制备方法

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102362685A (zh) * 2011-10-24 2012-02-29 浙江省医学科学院 一种玛咖复方饮料及其制备方法
CN102362685B (zh) * 2011-10-24 2012-10-17 浙江省医学科学院 一种玛咖复方饮料及其制备方法
CN103445165A (zh) * 2013-09-04 2013-12-18 百丽晨（上海）生物科技有限公司 一种用于改善亚健康状态的产品及其组合物
CN103734740A (zh) * 2013-12-26 2014-04-23 永安康健药业（武汉）有限公司 具机能调理作用的玛咖复方保健食品及制备方法
CN104905243A (zh) * 2015-01-06 2015-09-16 江苏丰颂生物科技有限公司 一种具有抗疲劳功能的玛咖生蚝组合物及其制备方法

Similar Documents

Publication Publication Date Title
IL185381A0 (en) Cis-2,4,5-triaryl-imidazolines and their use as anti-cancer medicaments
IL240523A0 (en) Activin-actrii antagonists and uses to increase red blood cell levels
IL194699A (en) Tetrahydropridridines, preparations containing them and uses in the preparation of drugs
IL188494A0 (en) Novel 2,4-dianlinopyrimidine derivatives, the preparation thereof, their use as medicaments, pharmaceutical compositions and, in particular, as ikk inhibitors
IL192053A (en) 2-Admentiluria derivatives as selective inhibitors of 1hsd-β11 and their use in drug preparation
MX2009007824A (es) Concentrado para suspension en aceites con sustancias activas agroquimicas microencapsuladas.
IL188732A (en) Use of ibuprofen and pamotidine for drug preparation
EP4309673A3 (de) Formulierungen von guanylatcyclase-c-agonisten und verfahren zur verwendung
PL2074122T3 (pl) Związki pirydo(2,3-D)pirymidynonowe i ich zastosowanie jako inhibitory PI3
PL1871277T3 (pl) Implant dentystyczny, elementy do połączenia z implantem dentystycznym oraz wewnętrzne połączenie pomiędzy implantem dentystycznym a każdym elementem
HUE054640T2 (hu) Poláris lipidekben gazdag tejösszetevõ és alkalmazásai
GEP20146087B (en) Paediatric solution comprising beta-blocker
PT2013246T (pt) Composições de aluminoxano, sua preparação e sua utilização em catálise
IL181683A0 (en) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
DE202007016505U1 (de) Re-Vital Kapseln für Männer
EP1652520A3 (de) Nützliche Formulierungen zur Behandlung von männlicher und weiblicher Impotenz
IL199168A0 (en) Indolizine derivatives and the use thereof as antidiabetics
TR200806300A2 (tr) Çözünürlük artırıcı farmasötlk formulasyon
IL188773A0 (en) Benzimidazoles and imidazopyridine derivatives and pharmaceutical compositions containing the same
IL174594A (en) MANIPULATED NKT CELLS MODULATING THE Th1/Th2 BALANCE, USES AND THERAPEUTIC COMPOSITIONS THEREOF IN THE TREATMENT OF IMMUNE-RELATED DISORDERS
WO2008035240A3 (en) Platelet freezing system
IL206379A0 (en) 17-HYDROXY-19-NOR-21-CARBOXYLIC ACID-STEROID ã?-LACTONE DERIVATIVE, USE THEREOF, AND MEDICAMENT CONTAINING THE DERIVATIVE
GB0610836D0 (en) The preparation of multipotent stem cells and the use thereof
GB201001001D0 (en) (11C)methoxy-radiolabelled 2,3',4,5'-tetramethylstilbene (TMS) and its preparation and use
AU2009100083A4 (en) An improved haircolour without ammonia

Legal Events

Date Code Title Description
R207 Utility model specification

Effective date: 20080320

R150 Utility model maintained after payment of first maintenance fee after three years

Effective date: 20101210

R157 Lapse of ip right after 6 years

Effective date: 20140603